ArticleOncoimmunology

Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study.

Yamin Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.